Nosopharm

Research and development of anti-infective drugs

Total raised

€2.4M

€2,400,000

Funding rounds

Investors

distinct backers

Active since

2020-10

latest 2020-10

Funding by year

EUR raised per year

High confidence

Raise-next likelihood15

base rate 42% for Early VC

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2020-11-01	Early VC	€2.4M	Alto Invest,Auriga Partners,Kreaxi	View deal →

same sector or country